Effect of sex hormones on the complement-related clinical disorder of hereditary angioedema.
D000614:Aminocaproates / Q000627:therapeutic use; D000799:Angioedema / Q000188:drug therapy / Q000235:genetics* / Q000276:immunology; D003172:Complement C1 / Q000032:analysis; D003174:Complement C1 Inactivator Proteins / Q000032:analysis; D003165:Complement System Proteins / Q000032:analysis*; D003613:Danazol / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008525:Medroxyprogesterone / Q000627:therapeutic use*; D011245:Pregnadienes / Q000627:therapeutic use*
D000614:Aminocaproates; D003172:Complement C1; D003174:Complement C1 Inactivator Proteins; D011245:Pregnadienes; D003165:Complement System Proteins; D008525:Medroxyprogesterone; D003613:Danazol